Gene Therapy for Non-Solar Cancer

Alex: I would like to start first reminding the paradigm of this amazingly long survivorship we were able to reach by sequencing treatment in the context of positive non-solar cancer. Solange: The sequence will be defined by the identification or at least the understanding of the mechanism of resistance to TIKI so if it is the case you'd like to state on an ALQ targeted therapy if you can and you have this big paradigm of bypass tracks other alternative pathways which can of course be met but can also be seen as a sign that KRS has been seeing some epithelial to meson chymal transition sometimes histological subtypes such as small cell  is not ALQ dependent